Cardiovascular risk prediction systems have to be adapted and updated to current national conditions

European Journal of Preventive Cardiology

Volumn 13, Issue 5, 2006, Pages 674-675

  Pyã¶rã¤lã¤, Kalevi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; EDITORIAL; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; SCORING SYSTEM;

CARDIOVASCULAR DISEASES; EUROPE; HUMANS; RISK FACTORS;

EID: 33749017908     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000239471.56626.4a     Document Type: Editorial

References (17)

1. Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–1331.
2. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434–1503.
3. British Cardiac Society, British Hyperlidaemia Association, British Hypertension Society and British Diabetes Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. BMJ 2000; 320: 705–708.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongville J, et al European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice Eur J Cardiovasc Prev Rehabil 2003; 10(Suppl 1):S1–S78.
6. New Zealand Guideline Group. Assessment and management of cardiovascular risk 2003. www.nzgg.org. [Accessed 23 July 2006].
7. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356–362.
8. Hense HW. Risk factor scoring for coronary heart disease. BMJ 2003; 327: 1238–1239.
9. Beswick A, Brindle P. Risk scoring in the assessment of cardiovascular risk. Curr Opin Lipidol 2006; 17: 375–386.
10. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al Esitmation of the ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
11. HeartScore programme. Interactive tool for predicting and managing heart attack and stroke risk. www.escardio.org/knowledge/decision_tools/heartscore. [Accessed 23 July 2006].
12. Wilhelmsen L, Wedel H, Conroy R, Fitzgerald T. The Swedish SCORE chart for cardiovascular risk. Better possibilities for prevention of cardiovascular disease. Läkartidningen 2004; 101: 11798–11801.
13. De Backer G, De Bacquer D, Brocher C, De Couleier S, Franck A, Krzentowsky G, et al Recommendations for the prevention of cardiovascular disease in clinical practice. J Pharm Belg 2005; 60: 41–50.
14. Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense HW. Assessment of the risk of fatal cardiovascular disease. The new SCORE-Germany tables for primary prevention [in German]. Deutsches ärzteblatt 2005; 102: 1808–1812.
15. Lindman AS, Selmer R, Tverdal A, Pedersen JI, Eggen AE, Veierod MB. The SCORE risk model applied on recent population survey in Norway compared to observed mortality in the general population. Eur J Cardiovasc Prev Rehabil 2006; 00: 0000–0000.
16. Getz L, Sigursson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J. Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ 2005; 331: 551–556.
17. Hartz I, Njolstad I, Eggen AE. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention. Eur Heart J 2005; 26: 1673–2680.